JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Search results for: 'research area pi3k akt signaling ampk'

Search results for: 'research area pi3k akt signaling ampk'

BA9152 SJ000291942

Summary: SJ000291942 is an activator of the classical bone morphogenetic protein signaling pathway.
BA9154 SY-LB-57

Summary: SY-LB-57 is a potent agonist of bone morphogenetic protein receptor signaling.
A8324 LDN-193189

Target: BMP and Other Activin Receptors

Summary: ALK inhibitor,potent and selective

insoluble in DMSO; insoluble in EtOH; insoluble in H2O
A9080 Streptomycin

Summary: Streptomycin (Agrept) is an antibiotic effective against M. tuberculosis and is widely used in tuberculosis (TB) research.

insoluble in DMSO; insoluble in EtOH; ≥53.6 mg/mL
B1047 GDC-0032

Target: PI3K

Summary: PI3Kα inhibitor

≥23.05 mg/mL
B5629 TAS 301

Summary: inhibitor of smooth muscle cell migration and proliferation, inhibits PKC signaling

Soluble in DMSO
BA8301 NPD10084

Summary: NPD10084 is a pyruvate kinase inhibitor that inhibits non-glycolytic signaling in cancer cells.
BA9090 Adavivint

Summary: Adavivint (SM04690; Lorecivivint) is a potent, selective inhibitor of typical signaling pathways.
BA9148 β-catenin-IN-6

Summary: β-catenin-IN-6 is an inhibitor targeting the typical wingless-related integration site signaling pathway.
A8315 NU7441 (KU-57788)
4 Citation

Target: PI3K|DNA-PK

Summary: DNA-PK inhibitor

insoluble in EtOH; insoluble in H2O; ≥4.13 mg/mL